The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: An exploratory subgroup analysis of JCOG1113.

被引：0
|
作者：
Yamada, Ikuhiro
Morizane, Chigusa
Okusaka, Takuji
Ogawa, Gakuto
Sato, Yuya
Ueno, Makoto
Ikeda, Masafumi
Sugimori, Kazuya
Fukutomi, Akira
Shimizu, Satoshi
Mizuno, Nobumasa
Yanagimoto, Hiroaki
Sano, Keiji
Tobimatsu, Kazutoshi
Yane, Kei
Nakamori, Shoji
Sata, Naohiro
Nishina, Tomohiro
Ishii, Hiroshi
Furuse, Junji
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
[2] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Natl Canc Ctr, Ctr Res Adm & Support, Tokyo, Japan
[5] Natl Canc Ctr, Japan Clin Oncol Grp, Data Ctr, Operat Off, Tokyo, Japan
[6] Kanagawa Canc Ctr, Hepatobiliary & Pancreat Med Oncol Div, Dept Gastroenterol, Yokohama, Kanagawa, Japan
[7] Natl Canc Ctr Hosp East, Chiba, Japan
[8] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa, Japan
[9] Shizuoka Prefectural Gen Hosp, Canc Ctr, Shizuoka, Japan
[10] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
[11] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan
[12] Kansai Med Univ, Osaka, Japan
[13] Teikyo Univ, Sch Med, Tokyo, Japan
[14] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan
[15] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan
[16] Natl Hosp Org Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan
[17] Jichi Med Univ, Shimotsuke, Tochigi, Japan
[18] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[19] Chiba Canc Ctr, Clin Res Ctr, Chiba, Japan
[20] Kyorin Univ, Fac Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study
    Fukutomi, Akira
    Furuse, Junji
    Okusaka, Takuji
    Miyazaki, Masaru
    Taketsuna, Masanori
    Koshiji, Minori
    Nimura, Yuji
    HPB, 2012, 14 (04) : 221 - 227
  • [22] Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial
    Klein, Oliver
    Kee, Damien
    Nagrial, Adnan
    Markman, Ben
    Underhill, Craig
    Michael, Michael
    Jackett, Louise
    Lum, Caroline
    Behren, Andreas
    Palmer, Jodie
    Tebbutt, Niall C.
    Carlino, Matteo S.
    Cebon, Jonathan
    JAMA ONCOLOGY, 2020, 6 (09) : 1405 - 1409
  • [23] Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer: A Retrospective Study
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Nabetani, Masashi
    Koizumi, Kazuya
    Hayashi, Takashi
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 498 - 504
  • [24] Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
    Eckel, F.
    Schmid, R. M.
    BRITISH JOURNAL OF CANCER, 2007, 96 (06) : 896 - 902
  • [25] Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
    F Eckel
    R M Schmid
    British Journal of Cancer, 2007, 96 : 896 - 902
  • [26] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Katayama, Hiroshi
    Ueno, Makoto
    Ikeda, Masafumi
    Ishii, Hiroshi
    Azuma, Takeshi
    Iguchi, Haruo
    Nakamori, Shoji
    Mizuno, Nobumasa
    Sata, Naohiro
    Sugimori, Kazuya
    Yamaguchi, Konsei
    Mine, Tetsuya
    Sano, Keiji
    Maguchi, Hiroyuki
    Shimizu, Kyoko
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
    Morizane, C.
    Okusaka, T.
    Mizusawa, J.
    Katayama, H.
    Ueno, M.
    Ikeda, M.
    Ozaka, M.
    Okano, N.
    Sugimori, K.
    Fukutomi, A.
    Hara, H.
    Mizuno, N.
    Yanagimoto, H.
    Wada, K.
    Tobimatsu, K.
    Yane, K.
    Nakamori, S.
    Yamaguchi, H.
    Asagi, A.
    Yukisawa, S.
    Kojima, Y.
    Kawabe, K.
    Kawamoto, Y.
    Sugimoto, R.
    Iwai, T.
    Nakamura, K.
    Miyakawa, H.
    Yamashita, T.
    Hosokawa, A.
    Ioka, T.
    Kato, N.
    Shioji, K.
    Shimizu, K.
    Nakagohri, T.
    Kamata, K.
    Ishii, H.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1950 - 1958
  • [28] Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Osamu Togawa
    Hirofumi Kogure
    Yukiko Ito
    Keisuke Yamamoto
    Suguru Mizuno
    Hiroshi Yagioka
    Yoko Yashima
    Kazumichi Kawakubo
    Toshihiko Arizumi
    Saburo Matsubara
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Nobuo Toda
    Minoru Tada
    Masao Omata
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 847 - 853
  • [29] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [30] Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
    Saisho, T
    Okusaka, T
    Ueno, H
    Morizane, C
    Okada, S
    HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1654 - 1658
12345